FindTrial
Sign In

A Clinical Study to Evaluate the Validity of Cardiopulmonary Function Variables Measured by the Cardiac Output Monitor HemoVista and the Lung Volume Monitor AirTom

Clinical Study to Evaluate the Performance of AirTom and HemoVista in order to Assess the Feasibility of a New Cardiopulmonary Monitor Combining Functionalities of AirTom and HemoVista

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010674
Enrollment
100
Registered
2025-06-24
Start date
2022-10-21
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals who voluntarily consent to participate in this clinical trial and have signed the informed consent form approved by the Institutional Review Board (IRB). 2. Individuals aged 18 years or older but under 80 years of age. 3. Individuals without underlying cardiovascular or pulmonary diseases.

Exclusion criteria

Exclusion criteria: 1. Patients implanted with electronic medical devices such as pacemakers or implantable cardioverter defibrillators (ICDs). 2. Individuals with skin damage at the electrode pad attachment sites. 3. Individuals whose electrode contact with the skin is insufficient due to wound dressings or similar coverings. 4. Individuals with a body mass index (BMI) of 40 or higher. 5. Individuals who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Stroke Volume;Cardiac output;Tidal Volume;Minute Volume—

Countries

Korea, Republic of

Contacts

Public ContactMi Ryeo Nam

Samsung Medical Center

nmr1010@hanmail.net+82-2-2008-4187

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026